Sanofi is the result of the merger of several French laboratories, including Synthélabo, Aventis – which emerged from the combination of Rhône-Poulenc and Hoechst – and the pharmaceutical activities of Sanofi-Synthélabo. The group is a global player in health and biotechnology, active in rare diseases, vaccines, and consumer healthcare. It has distinguished itself through major advancements such as glargine insulin (Lantus), a reference treatment for diabetes, and iconic vaccines against poliomyelitis, rabies, and influenza developed by Sanofi Pasteur. Sanofi invests in biotechnology research and the global production of vaccines, contributing to prevention and international health security.
Create a free account to unlock the AI analysis, news, momentum and full price history for SANOFI — and every other stock.
Create a free account